NCT06307418 is a NA clinical trial of Carer eSupport in Head and Neck Cancer, sponsored by Uppsala University.

Who is sponsoring NCT06307418?

NCT06307418 is sponsored by Uppsala University.

What drugs are being tested in NCT06307418?

Interventions in NCT06307418: Carer eSupport.

What condition does NCT06307418 study?

NCT06307418 studies Head and Neck Cancer.

Is NCT06307418 still recruiting?

NCT06307418 is currently recruiting now. Last updated 29 May 2025.

Last reviewed 2025-05-29 · How we verify

NCT06307418

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Internet-based Support for Informal Caregivers of Patients With Head and Neck Cancer - Carer eSupport

Recruiting now NA Last updated 29 May 2025

What this trial tests

NA trial testing Carer eSupport in Head and Neck Cancer in 110 participants. Currently enrolling.

Timeline

20 August 2024

Primary endpoint
31 October 2026

31 October 2026

Quick facts

Lead sponsor	Uppsala University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	110
Start date	20 August 2024
Primary completion	31 October 2026
Estimated completion	31 October 2026
Sites	4 locations across Sweden

Drugs / interventions tested

Carer eSupport

Conditions studied

Head and Neck Cancer — all drugs for Head and Neck Cancer →

Sponsor

Uppsala University

Who can join

18 and older, any sex, with Head and Neck Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this randomized controlled trial is to investigate the effects of internet-based support (Carer eSupport) on preparedness for caregiving in informal caregivers of patients with head and neck cancer. The main question\[s\] it aims to answer are: * What are the effects of internet-based support on informal caregivers preparedness for caregiving? * What are the effects of internet-based support on informal caregivers burden and wellbeing? Informal caregivers who are randomized to Carer eSupport will have access to Carer eSupport for 18 weeks and they will be asked to complete questionnaires (outcome measures) at: * baseline (before randomization) * 18 weeks (post-intervention) and at * 3 months after the intervention is completed (long term follow-up). Informal caregivers in the intervention group will be compared to informal caregivers who receive standard care support regarding preparedness for caregiving, caregiver burden and wellbeing.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The effect of internet-administered support (carer eSupport) on preparedness for caregiving in informal caregivers of patients with head and neck cancer compared with support as usual: a study protocol for a randomized controlled trial.
Johansson B, Cajander Å, Ahmad A, Ohlsson-Nevo E, et al · · 2024 · cited 1× · PMID 38637744 · DOI 10.1186/s12885-024-12273-y
The Development of a Web-Based Application to Support Informal Caregivers of Individuals With Head and Neck Cancer: Human-Centered Design Approach.
Ahmad A, Cajander Å, Langegård U, Johansson B, et al · · 2026 · PMID 41950374 · DOI 10.2196/81896

Verify or expand the search:

Other recruiting trials for Head and Neck Cancer

Currently open trials in the same condition.

NCT07318220 — Prehabilitation Protocol for Head and Neck Cancer Patients · NA · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07467083 — Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Unde · Phase 3 · recruiting
NCT07209189 — Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca · Phase 2 · recruiting
NCT06837480 — Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema · NA · recruiting

Other Uppsala University trials

Trials by the same sponsor.

NCT07517185 — The HIt HArd and hiT Early in Multiple Sclerosis Trial · Phase 2 · not yet recruiting
NCT07351149 — Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery · recruiting
NCT07461636 — Robotic-Assisted Pedicle Screw Placement in Spine Surgery · recruiting
NCT07273409 — Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not · NA · recruiting
NCT07352683 — Open TAP-block in Pediatric Abdominal Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06307418 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Uppsala University
Last refreshed: 29 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06307418.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing